{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T01:14:10Z","timestamp":1785374050824,"version":"3.55.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,1,29]],"date-time":"2012-01-29T00:00:00Z","timestamp":1327795200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s11908-012-0245-9","type":"journal-article","created":{"date-parts":[[2012,1,28]],"date-time":"2012-01-28T08:27:34Z","timestamp":1327739254000},"page":"147-154","source":"Crossref","is-referenced-by-count":9,"title":["Leukotriene Inhibitors in Sinusitis"],"prefix":"10.1007","volume":"14","author":[{"given":"John W.","family":"Steinke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,29]]},"reference":[{"key":"245_CR1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0194-5998(03)01397-4","volume":"129","author":"MS Benninger","year":"2003","unstructured":"Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003;129:S1\u2013S32.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"245_CR2","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/j.jaci.2004.09.029","volume":"114","author":"EO Meltzer","year":"2004","unstructured":"Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clincal research and patient care. J Allergy Clin Immunol. 2004;114:S155\u2013212.","journal-title":"J Allergy Clin Immunol"},{"key":"245_CR3","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.jaci.2005.09.048","volume":"116","author":"RG Slavin","year":"2005","unstructured":"Slavin RG, Spector SL, Berstein IL, et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol. 2005;116:S13\u201347.","journal-title":"J Allergy Clin Immunol"},{"key":"245_CR4","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Payne SC, Borish L, Steinke JW. Genetics and phenotyping in chronic sinusitis. J Allergy Clin Immunol. 2011;in press. Rather than lumping all forms of sinusitis together, this paper discusses the various subtypes of sinusitis and different approaches to treatment.","DOI":"10.1016\/j.jaci.2011.05.022"},{"key":"245_CR5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4049\/jimmunol.171.1.5","volume":"171","author":"AC Yopp","year":"2003","unstructured":"Yopp AC, Randolph GJ, Bromberg JS. Leukotrienes, sphingolipids, and leukocyte trafficking. J Immuol. 2003;171:5\u201310.","journal-title":"J Immuol"},{"key":"245_CR6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0014-5793(00)02374-7","volume":"487","author":"M Peters-Golden","year":"2001","unstructured":"Peters-Golden M, Brock TG. Intracellular compartmentalization of leukotriene synthesis: unexpected nuclear secrets. FEBS Lett. 2001;487:323\u20136.","journal-title":"FEBS Lett"},{"key":"245_CR7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1126\/science.1144346","volume":"317","author":"AD Ferguson","year":"2007","unstructured":"Ferguson AD, McKeever BM, Xu S, et al. Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein. Science. 2007;317:510\u20132.","journal-title":"Science"},{"key":"245_CR8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature05936","volume":"448","author":"H Ago","year":"2007","unstructured":"Ago H, Kanaoka Y, Irikura D, et al. Crystal structure of a human membrane protein involved in cysteinyl leukotriene biosynthesis. Nature. 2007;448:609\u201312.","journal-title":"Nature"},{"key":"245_CR9","doi-asserted-by":"crossref","first-page":"28902","DOI":"10.1074\/jbc.M203074200","volume":"277","author":"P Christmas","year":"2002","unstructured":"Christmas P, Weber BM, McKee M, et al. Membrane localization and topology of leukotriene C4 synthase. J Biol Chem. 2002;277:28902\u20138.","journal-title":"J Biol Chem"},{"key":"245_CR10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/21658","volume":"399","author":"KR Lynch","year":"1999","unstructured":"Lynch KR, O\u2019Neill GP, Liu Q, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature. 1999;399:789\u201393.","journal-title":"Nature"},{"key":"245_CR11","doi-asserted-by":"crossref","first-page":"30531","DOI":"10.1074\/jbc.M003490200","volume":"275","author":"CE Heise","year":"2000","unstructured":"Heise CE, O\u2019Dowd BF, Figueroa DJ, et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem. 2000;275:30531\u20136.","journal-title":"J Biol Chem"},{"key":"245_CR12","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/sj.bjp.0704991","volume":"137","author":"L Walch","year":"2002","unstructured":"Walch L, Norel X, Back M, et al. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle. Br J Pharmacol. 2002;137:1339\u201345.","journal-title":"Br J Pharmacol"},{"key":"245_CR13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bbrc.2005.09.052","volume":"337","author":"Y Nonaka","year":"2005","unstructured":"Nonaka Y, Hiramoto T, Fujita N. Identification of endogenous surrogate ligands for human P2Y12 receptors by in silico and in vitro methods. Biochem Biophys Res Commun. 2005;337:281\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"245_CR14","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1084\/jem.20091240","volume":"206","author":"S Paruchuri","year":"2009","unstructured":"\u2022\u2022 Paruchuri S, Tashimo H, Feng C, et al. Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor. J Exp Med. 2009;206:2543\u20132555. This is one of the first papers that describes a receptor for LTE 4 , providing functional evidence in support of previous pharmacological data.","journal-title":"J Exp Med"},{"key":"245_CR15","doi-asserted-by":"crossref","first-page":"16695","DOI":"10.1073\/pnas.0808993105","volume":"105","author":"A Maekawa","year":"2008","unstructured":"\u2022 Maekawa A, Kanaoka Y, Xing W, et al. Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors. Proc Natl Acad Sci U S A. 2008;105:16695\u201316700. Using knock-out mice this papers demonstrates that a receptor for LTE 4 exists based on responsiveness to LTE 4 in the absence of other known CysLT receptors.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"245_CR16","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1038\/sj.emboj.7601341","volume":"25","author":"P Ciana","year":"2006","unstructured":"Ciana P, Fumagalli M, Trincavelli ML, et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides\/cysteinyl-leukotrienes receptor. EMBO J. 2006;25:4615\u201327.","journal-title":"EMBO J"},{"key":"245_CR17","doi-asserted-by":"crossref","first-page":"11685","DOI":"10.1073\/pnas.0905364106","volume":"106","author":"A Maekawa","year":"2009","unstructured":"Maekawa A, Balestrieri B, Austen KF, et al. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4. Proc Natl Acad Sci U S A. 2009;106:11685\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"245_CR18","doi-asserted-by":"crossref","unstructured":"Wunder F, Tinel H, Kast R, et al. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor. Br J Pharmacol. 160:399\u2013409.","DOI":"10.1111\/j.1476-5381.2010.00730.x"},{"key":"245_CR19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1164\/ajrccm.163.1.2003101","volume":"163","author":"DJ Figueroa","year":"2001","unstructured":"Figueroa DJ, Breyer R, Defoe S, et al. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Crit Care Med. 2001;163:226\u201333.","journal-title":"Am J Crit Care Med"},{"key":"245_CR20","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1046\/j.1365-2222.2003.01786.x","volume":"33","author":"DJ Figueroa","year":"2003","unstructured":"Figueroa DJ, Borish L, Baramki D, et al. Expression of cysteinyl leukotriene synthetic and signaling proteins in inflammatory cells in active seasonal allergic rhinitis. Clin Exp Allergy. 2003;33:1380\u20138.","journal-title":"Clin Exp Allergy"},{"key":"245_CR21","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMoa013508","volume":"347","author":"AR Sousa","year":"2002","unstructured":"Sousa AR, Parikh A, Scadding G, et al. Leukotriene-receptor expression on nasal mucosal inflammatory cells in asprin-sensitive rhinosinusitis. N Engl J Med. 2002;347:1493\u20139.","journal-title":"N Engl J Med"},{"key":"245_CR22","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1161\/01.ATV.0000082689.46538.DF","volume":"23","author":"M Sjostrom","year":"2003","unstructured":"Sjostrom M, Johansson AS, Schroder O, et al. Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endotheilial cells. Arterioscler Thromb Vasc Biol. 2003;23:E37\u201341.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"245_CR23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jaci.2006.08.028","volume":"119","author":"H Yoshisue","year":"2007","unstructured":"Yoshisue H, Kirkham-Brown J, Healy E, et al. Cysteinyl leukotrienes synergize with growth factors too induce proliferation of human bronchial fibroblasts. J Allergy Clin Immunol. 2007;119:132\u201340.","journal-title":"J Allergy Clin Immunol"},{"key":"245_CR24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1165\/rcmb.2003-0071OC","volume":"30","author":"JW Steinke","year":"2004","unstructured":"Steinke JW, Crouse CD, Bradley D, et al. Characterization of interleukin-4 stimulated nasal polyp fibroblasts. Am J Respir Cell Mol Biol. 2004;30:212\u20139.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"245_CR25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0952-3278(03)00073-5","volume":"69","author":"AM Tager","year":"2003","unstructured":"Tager AM, Luster AD. BLT1 and BLT2: the leukotriene B(4) receptors. Prost Leukot Essent Fatty Acids. 2003;69:123\u201334.","journal-title":"Prost Leukot Essent Fatty Acids"},{"key":"245_CR26","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/S0024-3205(01)01007-4","volume":"68","author":"T Yokomizo","year":"2001","unstructured":"Yokomizo T, Izumi T, Shimizu T. Co-expression of two LTB4 receptors in human mononuclear cells. Life Sci. 2001;68:2207\u201312.","journal-title":"Life Sci"},{"key":"245_CR27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1084\/jem.20020044","volume":"195","author":"EA Mellor","year":"2002","unstructured":"Mellor EA, Austen KF, Boyce JA. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J Exp Med. 2002;195:583\u201392.","journal-title":"J Exp Med"},{"key":"245_CR28","doi-asserted-by":"crossref","first-page":"11589","DOI":"10.1073\/pnas.2034927100","volume":"100","author":"EA Mellor","year":"2003","unstructured":"Mellor EA, Frank N, Soler D, et al. Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R. Proc Natl Acad Sci U S A. 2003;100:11589\u201393.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"245_CR29","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.4049\/jimmunol.167.5.2855","volume":"167","author":"M Thivierge","year":"2001","unstructured":"Thivierge M, Stankova J, Rola-Pleszczynski M. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol. 2001;167:2855\u201360.","journal-title":"J Immunol"},{"key":"245_CR30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1165\/rcmb.2006-0252OC","volume":"36","author":"SB Early","year":"2007","unstructured":"Early SB, Barekzi E, Negri J, et al. Concordant modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-\u03b3 on peripheral immune cells. Am J Respir Cell Mol Biol. 2007;36:715\u201320.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"245_CR31","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1378\/chest.128.5.3148","volume":"128","author":"M Fujii","year":"2005","unstructured":"Fujii M, Tanaka H, Abe S. Interferon-gamma up-regulates expression of cysteinyl leukotriene type 2 receptors on eosinophils in asthmatic patients. Chest. 2005;128:3148\u201355.","journal-title":"Chest"},{"key":"245_CR32","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/01.ATV.0000082690.23131.CB","volume":"23","author":"K Lotzer","year":"2003","unstructured":"Lotzer K, Spanbroek R, Hildner M, et al. Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis. Arterioscler Thromb Vasc Biol. 2003;23:e32\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"245_CR33","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.4049\/jimmunol.178.8.5262","volume":"178","author":"G Woszczek","year":"2007","unstructured":"Woszczek G, Chen LY, Nagineni S, et al. IFN-gamma induces cysteinyl leukotriene receptor 2 expression and enhances the responsiveness of human endothelial cells to cysteinyl leukotrienes. J Immunol. 2007;178:5262\u201370.","journal-title":"J Immunol"},{"key":"245_CR34","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.4049\/jimmunol.165.9.5221","volume":"165","author":"M Thivierge","year":"2000","unstructured":"Thivierge M, Doty M, Johnson J, et al. IL-5 up-regulates cysteinyl leukotriene 1 receptor expression in HL-60 cells differentiated into eosinophils. J Immunol. 2000;165:5221\u20136.","journal-title":"J Immunol"},{"key":"245_CR35","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1073\/pnas.0602208103","volume":"103","author":"H Qiu","year":"2006","unstructured":"Qiu H, Johansson AS, Sjostrom M, et al. Differential induction of BLT receptor expression on human endothelial cells by lipopolysaccharide, cytokines, and leukotriene B4. Proc Natl Acad Sci U S A. 2006;103:6913\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"245_CR36","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","volume":"68","author":"M Samter","year":"1968","unstructured":"Samter M, Beers Jr RF. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968;68:975\u201383.","journal-title":"Ann Intern Med"},{"key":"245_CR37","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1136\/thorax.55.suppl_2.S42","volume":"55","author":"A Szczeklik","year":"2000","unstructured":"Szczeklik A, Nizankowska E. Clinical features and diagnosis of aspirin induced asthma. Thorax. 2000;55:S42\u20136.","journal-title":"Thorax"},{"key":"245_CR38","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1067\/mai.2003.67","volume":"111","author":"JW Steinke","year":"2003","unstructured":"Steinke JW, Bradley D, Arango P, et al. Cytseinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma. J Allergy Clin Immunol. 2003;111:342\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"245_CR39","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaci.2005.02.029","volume":"115","author":"CA Perez-Novo","year":"2005","unstructured":"Perez-Novo CA, Watelet JB, Claeys C, et al. Prostaglandin, leukotiene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol. 2005;115:1189\u201396.","journal-title":"J Allergy Clin Immunol"},{"key":"245_CR40","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1172\/JCI620","volume":"101","author":"AS Cowburn","year":"1998","unstructured":"Cowburn AS, Sladek K, Soja J, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest. 1998;101:834\u201346.","journal-title":"J Clin Invest"},{"key":"245_CR41","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/path.1979","volume":"209","author":"J Adamjee","year":"2006","unstructured":"Adamjee J, Suh YJ, Park HS, et al. Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma. J Pathol. 2006;209:392\u20139.","journal-title":"J Pathol"},{"key":"245_CR42","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","volume":"143","author":"PE Christie","year":"1991","unstructured":"Christie PE, Tagari P, Ford-Hutchinson AW, et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis. 1991;143:1025\u20139.","journal-title":"Am Rev Respir Dis"},{"key":"245_CR43","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jaci.2004.10.051","volume":"115","author":"C Corrigan","year":"2005","unstructured":"Corrigan C, Mallett K, Ying S, et al. Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis. J Allergy Clin Immunol. 2005;115:316\u201322.","journal-title":"J Allergy Clin Immunol"},{"key":"245_CR44","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0091-6749(97)80019-X","volume":"99","author":"C Bachert","year":"1997","unstructured":"Bachert C, Wagenmann M, Hauser U, et al. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol. 1997;99:837\u201342.","journal-title":"J Allergy Clin Immunol"},{"key":"245_CR45","first-page":"130","volume":"11","author":"C Bachert","year":"1999","unstructured":"Bachert C, Gevaert P, van Cauwenberge P. Nasal polyposis- a new concept on the formation of polyps. ACI International. 1999;11:130\u20135.","journal-title":"ACI International"},{"key":"245_CR46","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/0091-6749(94)90379-4","volume":"93","author":"A Elovic","year":"1994","unstructured":"Elovic A, Wong DT, Weller PF, et al. Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol. 1994;93:864\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"245_CR47","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1398-9995.2006.01225.x","volume":"61","author":"T Zele Van","year":"2006","unstructured":"Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61:1280\u20139.","journal-title":"Allergy"},{"key":"245_CR48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1165\/ajrcmb.17.6.2865","volume":"17","author":"EM Minshall","year":"1997","unstructured":"Minshall EM, Cameron L, Lavigne F, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Amer J Resp Cell Mol Biol. 1997;17:683\u201390.","journal-title":"Amer J Resp Cell Mol Biol"},{"key":"245_CR49","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1046\/j.1365-2222.1998.00380.x","volume":"28","author":"DL Hamilos","year":"1998","unstructured":"Hamilos DL, Leung DYM, Huston DP, et al. GM-CSF, IL-5, and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis. Clin Exp Allergy. 1998;28:1145\u201352.","journal-title":"Clin Exp Allergy"},{"key":"245_CR50","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1447","volume":"148","author":"E Israel","year":"1993","unstructured":"Israel E, Fischer AR, Rosenberg MA, et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Amer Rev Respir Dis. 1993;148:1447\u201351.","journal-title":"Amer Rev Respir Dis"},{"key":"245_CR51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1183\/09031936.93.06030391","volume":"6","author":"K Sladek","year":"1993","unstructured":"Sladek K, Szczeklik A. Cysteinyl leukotrienes overproduction and mast cell activation in aspirn-provoked bronchospasm in asthma. Eur Respir J. 1993;6:391\u20139.","journal-title":"Eur Respir J"},{"key":"245_CR52","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-6749(99)70324-6","volume":"104","author":"PJ Daffern","year":"1999","unstructured":"Daffern PJ, Muilenburg D, Hugli TE, et al. Association of urinary leukotriene E4 excretion during aspirin challenges with severity of resiratory responses. J Allergy Clin Immunol. 1999;104:559\u201364.","journal-title":"J Allergy Clin Immunol"},{"key":"245_CR53","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/ajrccm\/140.1.148","volume":"140","author":"JP Arm","year":"1989","unstructured":"Arm JP, O\u2019Hickey S, Spur BW, et al. Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma. Am Rev Respir Dis. 1989;140:148\u201353.","journal-title":"Am Rev Respir Dis"},{"key":"245_CR54","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00001813-200506000-00001","volume":"16","author":"XZ Ding","year":"2005","unstructured":"Ding XZ, Talamonti MS, Bell Jr RH, et al. A novel anti-pancreatic cancer agent, LY293111. Anti Canc Drugs. 2005;16:467\u201373.","journal-title":"Anti Canc Drugs"},{"key":"245_CR55","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/ajrccm.157.4.9707089","volume":"157","author":"B Dahlen","year":"1998","unstructured":"Dahlen B, Nizankowska E, Szczeklik A. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Critc Care Med. 1998;157:1187\u201394.","journal-title":"Am J Respir Critc Care Med"},{"key":"245_CR56","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/000348940511401209","volume":"114","author":"DA Kieff","year":"2005","unstructured":"Kieff DA, Busaba NY. Efficacy of montelukast in the treatment of nasal polyposis. Ann Otol Rhinol Laryngol. 2005;114:941\u20135.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"245_CR57","first-page":"51","volume":"21","author":"C Schaper","year":"2011","unstructured":"\u2022 Schaper C, Noga O, Koch B, et al. Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis. J Investig Allergol Clin Immunol. 2011;21:51\u201358. Monteluekast was shown to mediate slight improvements in chronic sinusitis symptoms and reduction in nasal polyps.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"245_CR58","first-page":"142","volume":"39","author":"AM Wilson","year":"2001","unstructured":"Wilson AM, White PS, Gardiner Q, et al. Effects of leukotriene receptor antagonist therapy in patients with chronic rhinosinusitis in a real life rhinology clinic setting. Rhinology. 2001;39:142\u20136.","journal-title":"Rhinology"},{"key":"245_CR59","first-page":"18","volume":"79","author":"SM Parnes","year":"2000","unstructured":"Parnes SM, Churna AV. Acute effects of antileukotrienes on sinonasal polyposis and sinusitis. ENT Journal. 2000;79:18\u201321.","journal-title":"ENT Journal"},{"key":"245_CR60","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00020840-200306000-00010","volume":"11","author":"SM Parnes","year":"2003","unstructured":"Parnes SM. The role of leukotriene inhibitors in patients with paranasal sinus disease. Curr Opin Otolaryngol Head Neck Surg. 2003;11:184\u201391.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"245_CR61","first-page":"336","volume":"20","author":"L Rienzo Di","year":"2000","unstructured":"Di Rienzo L, Artuso A, Cerqua N. Antileukotrienes in the prevention of postoperative recurrence of nasal polyposis in ASA syndrome. Acta Otorhinolaryngol Ital. 2000;20:336\u201342.","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"245_CR62","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-2001-17832","volume":"80","author":"T Grundmann","year":"2001","unstructured":"Grundmann T, Topfner M. Treatment of ASS-Associated Polyposis (ASSAP) with a cysteinyl leukotriene receptor antagonist - a prospective drug study on its antiinflammatory effects. Laryngorhinootologie. 2001;80:576\u201382.","journal-title":"Laryngorhinootologie"},{"key":"245_CR63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.193.1.123","volume":"193","author":"FH Hsieh","year":"2001","unstructured":"Hsieh FH, Lam BK, Penrose JF, et al. T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C4 synthase expression by interleukin 4. J Exp Med. 2001;193:123\u201333.","journal-title":"J Exp Med"},{"key":"245_CR64","doi-asserted-by":"crossref","first-page":"7964","DOI":"10.1073\/pnas.141221498","volume":"98","author":"EA Mellor","year":"2001","unstructured":"Mellor EA, Maekawa A, Austen KF, et al. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc Natl Acad Sci USA. 2001;98:7964\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"245_CR65","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.4049\/jimmunol.175.8.5430","volume":"175","author":"DA Lin","year":"2005","unstructured":"Lin DA, Boyce JA. IL-4 regulates MEK expression required for lysophosphatidic acid-mediated chemokine generation by human mast cells. J Immunol. 2005;175:5430\u20138.","journal-title":"J Immunol"},{"key":"245_CR66","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2006.05.031","volume":"118","author":"P Gevaert","year":"2006","unstructured":"Gevaert P, Lang-Loidolt D, Lackner A, et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol. 2006;118:1133\u201341.","journal-title":"J Allergy Clin Immunol"},{"key":"245_CR67","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2010.03.028","volume":"125","author":"S Kim","year":"2010","unstructured":"\u2022\u2022 Kim S, Marigowda G, Oren E, et al. Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome. J Allergy Clin Immunol. 2010;125:1336\u20131343. Anti-IL-5 treatment reduces eosinophil number and therefore leukotriene levels in sinus tissue. An additional benefit would be the reduction of steroid levels required in the treatment of chronic sinusitis and associated nasal polyposis.","journal-title":"J Allergy Clin Immunol"},{"key":"245_CR68","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajh.20088","volume":"77","author":"BJ Bain","year":"2004","unstructured":"Bain BJ. Relationship between idiopathic hypereosinophilic syndrome, eosinophilic leukemia, and systemic mastocytosis. Am J Hematol. 2004;77:82\u20135.","journal-title":"Am J Hematol"},{"key":"245_CR69","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0002-9343(03)00475-3","volume":"115","author":"MJ Koury","year":"2003","unstructured":"Koury MJ, Newman JH, Murray JJ. Reversal of hypereosinophilic syndrome and lymphomatoid papulosis with mepolizumab and imatinib. Am J Med. 2003;115:587\u20139.","journal-title":"Am J Med"},{"key":"245_CR70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00020840-200502000-00013","volume":"13","author":"D Amrol","year":"2005","unstructured":"Amrol D, Murray JJ. Alternative medical treatment strategies for chronic hyperplastic eosinophilic sinusitis. Curr Opin Otolaryngol Head Neck Surg. 2005;13:55\u20139.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"245_CR71","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00005537-200402000-00019","volume":"114","author":"B Wallwork","year":"2004","unstructured":"Wallwork B, Coman W, Mackay-Sim A, et al. Effect of clarithromycin on nuclear factor-kappa B and transforming growth factor-beta in chronic rhinosinusitis. Laryngoscope. 2004;114:286\u201390.","journal-title":"Laryngoscope"},{"key":"245_CR72","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3950\/jibiinkoka.105.1189","volume":"105","author":"S Katsuta","year":"2002","unstructured":"Katsuta S, Osafune H, Takita R, et al. Therapeutic effect of roxithromycin on chronic sinusitis with nasal \u2013 polyps clinical, computed tomography, and electron microscopy analysis. Nihon Jibiinkoka Gakkai Kaiho. 2002;105:1189\u201397.","journal-title":"Nihon Jibiinkoka Gakkai Kaiho"},{"key":"245_CR73","first-page":"417","volume":"32","author":"JD Bradley","year":"2005","unstructured":"Bradley JD, Dmitrienko AA, Kivitz AJ, et al. A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis. J Rheumatol. 2005;32:417\u201323.","journal-title":"J Rheumatol"},{"key":"245_CR74","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0022-3565(25)10471-0","volume":"263","author":"A Miyake","year":"1992","unstructured":"Miyake A, Yamamoto H, Takebayashi Y, et al. The novel natural product YM-26567-1 [(+)-trans-4-(3-dodecanoyl-2,4,6- trihydroxyphenyl)-7-hydroxy-2-(4-hydroxyphenyl)chroman]: a competitive inhibitor of group II phospholipase A2. J Pharmacol Exp Ther. 1992;263:1302\u20137.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-012-0245-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-012-0245-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-012-0245-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T10:09:28Z","timestamp":1742378968000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-012-0245-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,29]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["245"],"URL":"https:\/\/doi.org\/10.1007\/s11908-012-0245-9","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,29]]}}}